SBFM FY 2018 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$447,200

Gross Profit

$56,11912.5% margin

Operating Income

-$1M-261.0% margin

Net Income

-$2M-482.1% margin

EPS (Diluted)

$-142.00

Cash Flow

Operating Cash Flow

-$512,806

Free Cash Flow

-$531,656

Stock-Based Comp.

$676,100

Balance Sheet

Total Assets

$1M

Total Liabilities

$1M

Stockholders' Equity

-$55,753

Cash & Equivalents

$115,216

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$447,200	$0	—
Gross Profit	$56,119	-$6,629	+946.6%
Operating Income	-$1M	-$857,190	-36.1%
Net Income	-$2M	-$1M	-107.3%